Drug
Ctim 76
Ctim 76: highest development phase Phase 1, developed by Context Therapeutics Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Context Therapeutics Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| CTIM-76 NCT06515613 | Phase 1 | Platinum-resistant Ovarian Cancer |
Latest
No recent events.
Follow Ctim 76 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.